
Limoneira Co
NASDAQ:LMNR

Limoneira Co?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.84
28.91
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Limoneira Co hold over its rivals?
What risks and challenges
does Limoneira Co face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Limoneira Co.
Provide an overview of the primary business activities
of Limoneira Co.
What unique competitive advantages
does Limoneira Co hold over its rivals?
What risks and challenges
does Limoneira Co face in the near future?
Has there been any significant insider trading activity
in Limoneira Co recently?
Summarize the latest earnings call
of Limoneira Co.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Limoneira Co.
Provide P/S
for Limoneira Co.
Provide P/E
for Limoneira Co.
Provide P/OCF
for Limoneira Co.
Provide P/FCFE
for Limoneira Co.
Provide P/B
for Limoneira Co.
Provide EV/S
for Limoneira Co.
Provide EV/GP
for Limoneira Co.
Provide EV/EBITDA
for Limoneira Co.
Provide EV/EBIT
for Limoneira Co.
Provide EV/OCF
for Limoneira Co.
Provide EV/FCFF
for Limoneira Co.
Provide EV/IC
for Limoneira Co.
Show me price targets
for Limoneira Co made by professional analysts.
What are the Revenue projections
for Limoneira Co?
How accurate were the past Revenue estimates
for Limoneira Co?
What are the Net Income projections
for Limoneira Co?
How accurate were the past Net Income estimates
for Limoneira Co?
What are the EPS projections
for Limoneira Co?
How accurate were the past EPS estimates
for Limoneira Co?
What are the EBIT projections
for Limoneira Co?
How accurate were the past EBIT estimates
for Limoneira Co?
Compare the revenue forecasts
for Limoneira Co with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Limoneira Co and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Limoneira Co against its competitors.
Analyze the profit margins
(gross, operating, and net) of Limoneira Co compared to its peers.
Compare the P/E ratios
of Limoneira Co against its peers.
Discuss the investment returns and shareholder value creation
comparing Limoneira Co with its peers.
Analyze the financial leverage
of Limoneira Co compared to its main competitors.
Show all profitability ratios
for Limoneira Co.
Provide ROE
for Limoneira Co.
Provide ROA
for Limoneira Co.
Provide ROIC
for Limoneira Co.
Provide ROCE
for Limoneira Co.
Provide Gross Margin
for Limoneira Co.
Provide Operating Margin
for Limoneira Co.
Provide Net Margin
for Limoneira Co.
Provide FCF Margin
for Limoneira Co.
Show all solvency ratios
for Limoneira Co.
Provide D/E Ratio
for Limoneira Co.
Provide D/A Ratio
for Limoneira Co.
Provide Interest Coverage Ratio
for Limoneira Co.
Provide Altman Z-Score Ratio
for Limoneira Co.
Provide Quick Ratio
for Limoneira Co.
Provide Current Ratio
for Limoneira Co.
Provide Cash Ratio
for Limoneira Co.
What is the historical Revenue growth
over the last 5 years for Limoneira Co?
What is the historical Net Income growth
over the last 5 years for Limoneira Co?
What is the current Free Cash Flow
of Limoneira Co?
Discuss the annual earnings per share (EPS)
trend over the past five years for Limoneira Co.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Limoneira Co
NASDAQ:LMNR
|
275.2m USD | 70.5 | |
US |
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
21.9B EUR | 12.6 |
|
SG |
![]() |
Wilmar International Ltd
SGX:F34
|
18.1B SGD | 3.7 |
|
US |
![]() |
Bunge Ltd
NYSE:BG
|
11.3B USD | 6.4 |
|
CN |
![]() |
Tongwei Co Ltd
SSE:600438
|
68.1B CNY | -14.3 |
|
US |
![]() |
Ingredion Inc
NYSE:INGR
|
9B USD | 7.7 |
|
MY |
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
31.3B MYR | 10.4 |
|
US |
![]() |
Darling Ingredients Inc
NYSE:DAR
|
6.1B USD | 12.2 |
|
CN |
![]() |
New Hope Liuhe Co Ltd
SZSE:000876
|
42.5B CNY | 20.9 |
|
MY |
![]() |
IOI Corporation Bhd
KLSE:IOICORP
|
22.8B MYR | 14.1 |
|
MY |
K
|
Kuala Lumpur Kepong Bhd
KLSE:KLK
|
22.4B MYR | 10.7 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Limoneira Co
NASDAQ:LMNR
|
Average EV/EBITDA:
16.9
70.5
|
121%
|
0.6 | |
US |
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
12.6
|
12%
|
1.1 |
|
SG |
![]() |
Wilmar International Ltd
SGX:F34
|
3.7
|
6%
|
0.6 |
|
US |
![]() |
Bunge Ltd
NYSE:BG
|
6.4
|
7%
|
0.9 |
|
CN |
![]() |
Tongwei Co Ltd
SSE:600438
|
Negative Multiple: -14.3 | N/A | N/A |
|
US |
![]() |
Ingredion Inc
NYSE:INGR
|
7.7
|
4%
|
1.9 |
|
MY |
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
10.4
|
N/A | N/A |
|
US |
![]() |
Darling Ingredients Inc
NYSE:DAR
|
12.2
|
24%
|
0.5 |
|
CN |
![]() |
New Hope Liuhe Co Ltd
SZSE:000876
|
20.9
|
91%
|
0.2 |
|
MY |
![]() |
IOI Corporation Bhd
KLSE:IOICORP
|
14.1
|
8%
|
1.8 |
|
MY |
K
|
Kuala Lumpur Kepong Bhd
KLSE:KLK
|
10.7
|
8%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.